Background: Adding short-term psychodynamic psychotherapy (STPP) to antidepressants increases treatment efficacy, but it is unclear which patients benefit specifically. This study examined efficacy moderators of combined treatment (STPP + antidepressants) antidepressants for adults with depression.
Methods: For this systematic review and meta-analysis (PROSPERO registration number: CRD42017056029), we searched PubMed, PsycINFO, Embase.com, and the Cochrane Library from inception to 1 January 2022. We included randomized clinical trials comparing combined treatment (antidepressants + individual outpatient STPP) antidepressants in the acute-phase treatment of depression in adults. Individual participant data were requested and analyzed combinedly using mixed-effects models (adding Cochrane risk of bias items as covariates) and an exploratory machine learning technique. The primary outcome was post-treatment depression symptom level.
Results: Data were obtained for all seven trials identified (100%, = 482, combined: = 238, antidepressants: = 244). Adding STPP to antidepressants was more efficacious for patients with high rather than low baseline depression levels [ = -0.49, 95% confidence interval (CI) -0.61 to -0.37, < 0.0001] and for patients with a depressive episode duration of >2 years rather than <1 year ( = -0.68, 95% CI -1.31 to -0.05, = 0.03) and than 1-2 years ( = -0.86, 95% CI -1.66 to -0.06, = 0.04). Heterogeneity was low. Effects were replicated in analyses controlling for risk of bias.
Conclusions: To our knowledge, this is the first study that examines moderators across trials assessing the addition of STPP to antidepressants. These findings need validation but suggest that depression severity and episode duration are factors to consider when adding STPP to antidepressants and might contribute to personalizing treatment selection for depression.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520584 | PMC |
http://dx.doi.org/10.1017/S0033291722003270 | DOI Listing |
Trends Psychiatry Psychother
April 2024
Department of Neurosciences 'Rita Levi Montalcini', University of Torino, Turin, Italy. Psychiatric Unit, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.
Introduction: Recent guidelines on depressive disorders suggest a combination of antidepressants and psychotherapy in case of moderate to severe symptomatology. While cognitive behavioral therapy and interpersonal therapy are the most investigated interventions, psychodynamic psychotherapies have been less explored.
Objective: The aim of this paper is to systematically review literature data on the efficacy of shortterm psychodynamic psychotherapy (STPP) in combination with antidepressants in the treatment of depressive disorders, focusing both on short and on long-term results and on potential moderators that could influence its effectiveness.
Australas Psychiatry
June 2023
Centre for Mental Health, Swinburne University of Technology, Hawthorn, VIC, Australia.
Objective: To compare the 2022 NICE guidelines (NG222) and 2020 RANZCP clinical practice guidelines (MDcpg) recommendations for the treatment of depression using psychodynamic psychotherapy.
Conclusions: Both guidelines recommend psychological interventions first-line. However, only short-term psychodynamic psychotherapy (STPP) is recommended, and in the NG222 it is ranked last for less severe depression and 7th for more severe depression.
J Affect Disord
March 2023
Department of Medicine and Surgery, Section of Psychiatry, University of Insubria, Varese, VA, Italy. Electronic address:
Introduction: Depression is one of the leading diseases globally. It can severely interfere with daily and occupational functioning of people affected. Both pharmacological interventions and psychotherapy are used for adult depression.
View Article and Find Full Text PDFPsychol Med
October 2023
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Background: Adding short-term psychodynamic psychotherapy (STPP) to antidepressants increases treatment efficacy, but it is unclear which patients benefit specifically. This study examined efficacy moderators of combined treatment (STPP + antidepressants) antidepressants for adults with depression.
Methods: For this systematic review and meta-analysis (PROSPERO registration number: CRD42017056029), we searched PubMed, PsycINFO, Embase.
Clin Psychol Rev
August 2020
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Purpose: We examined the efficacy of adding short-term psychodynamic psychotherapy (STPP) to antidepressants in the treatment of depression by means of a systematic review and meta-analysis of individual participant data, which is currently considered the most reliable method for evidence synthesis.
Results: A thorough systematic literature search resulted in 7 studies comparing combined treatment of antidepressants and STPP versus antidepressant mono-therapy (n = 3) or versus antidepressants and brief supportive psychotherapy (n = 4). Individual participant data were obtained for all these studies and totaled 482 participants.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!